Fennec Pharmaceuticals Inc

TSX : FRX

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Information

Website
https://www.fennecpharma.com
Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
United States

Price

CAD 6.26

Symbol

FRX

Type

Common Stock

Previous Close

 :

6.15

52 Week Range

 :

6.14 - 15.43

Volume

 :

13,100.00

Average Volume

 :

3,850.00

High

 :

6.28

Low

 :

6.22

Change

 :

0.11

Percent change (%)

 :

1.79

Stakeville

A Free-to-Play Trading Game. Sharpen your skills, trade stocks, and have fun!

Play Now
Getting Started
Get Your Free Account For Educational Purpose Knowledgebase
Legal
Cookie Policy Privacy Policy Terms & Conditions
Customer Service
Help Desk Support Stakeville Newsletter
Stay Connected
Contact Us Official Blog About Us
Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...